Home Biosimilar Antibodies Metabolism Others antibody Osocimab (Anti-F11 / Factor XI) For research use only.
Not for use in humans.

Osocimab (Anti-F11 / Factor XI)

Synonyms: BAY 1213790

Osocimab (Anti-F11 / Factor XI) is an antibody targeting Factor FXI. FXI inhibition may reduce the risk of thrombosis. Osocimab inhibits thrombin generation, and prolongs activated partial thromboplastin time. Osocimab exhibits anticoagulant effects. MW: 145.5 KD.

Osocimab (Anti-F11 / Factor XI)

Purity & Quality Control

≥99

Biological Activity

Description Osocimab (Anti-F11 / Factor XI) is an antibody targeting Factor FXI. FXI inhibition may reduce the risk of thrombosis. Osocimab inhibits thrombin generation, and prolongs activated partial thromboplastin time. Osocimab exhibits anticoagulant effects. MW: 145.5 KD.

Product Details

CAS No. 2056878-75-0
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Osocimab (Anti-F11 / Factor XI) | Osocimab (Anti-F11 / Factor XI) supplier | purchase Osocimab (Anti-F11 / Factor XI) | Osocimab (Anti-F11 / Factor XI) cost | Osocimab (Anti-F11 / Factor XI) manufacturer | order Osocimab (Anti-F11 / Factor XI) | Osocimab (Anti-F11 / Factor XI) distributor